Export 9 results:
Author Title [ Type(Desc)] Year
Filters: Author is Patel, SM  [Clear All Filters]
Journal Article
S. M. Patel, Atmar, R. L., Sahly, H. M. El, Guo, K., Hill, H., and Keitel, W. A., Direct Comparison of an Inactivated Subvirion Influenza A Virus Subtype H5N1 Vaccine Administered by the Intradermal and Intramuscular Routes, J Infect Dis, vol. 206, pp. 1069-1077, 2012.
J. E. Ledgerwood, Bellamy, A. R., Belshe, R., Bernstein, D. I., Edupuganti, S., Patel, S. M., Renehan, P., Zajdowicz, T., Schwartz, R., Koup, R., Bailer, R. T., Yamshchikov, G. V., Enama, M. E., Sarwar, U., Larkin, B., Graham, B. S., and Team, andThe V. R. C. 70, DNA Priming for Seasonal Influenza Vaccine: a Phase 1b Double-Blind Randomized Clinical Trial, PLoS One, vol. 10, p. e0125914, 2015.
D. I. Bernstein, Jackson, L., Patel, S. M., Sahly, H. M., Spearman, P., Rouphael, N., Jr., T. L. Rudge, Hill, H., and Goll, J. B., Immunogenicity and Safety of Four Different Dosing Regimens of Anthrax Vaccine Adsorbed for Post-Exposure Prophylaxis for Anthrax in Adults, Vaccine, vol. 32, pp. 6284-6293, 2014.
L. A. Jackson, Patel, S. M., Swamy, G. K., Frey, S. E., Creech, C. B., Munoz, F. M., Artal, R., Keitel, W. A., Noah, D. L., Petrie, C. R., Wolff, M., and Edwards, K. M., Immunogenicity of an Inactivated Monovalent 2009 H1N1 Influenza Vaccine in Pregnant Women, J Infect Dis, vol. 204, pp. 854-863, 2011.
S. E. Frey, Bernstein, D. I., Brady, R. C., Keitel, W. A., Sahly, H. E., Rouphael, N. G., Mulligan, M. J., Atmar, R. L., Edupuganti, S., Patel, S. M., Dickey, M., Graham, I., Anderson, E. L., Noah, D. L., Hill, H., Wolff, M., and Belshe, R. B., Phase II Trial in Adults of Concurrent or Sequential 2009 Pandemic H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations, Vaccine, vol. 33, pp. 163-173, 2015.
P. L. Winokur, Patel, S. M., Brady, R., Chen, W. H., El-Kamary, S. S., Edwards, K., Creech, C. B., Frey, S., Keitel, W. A., Belshe, R., Walter, E., Bellamy, A., Hill, H., and Group, T. V. T. E. U. - H. 3Nv, Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine, J Infect Dis, vol. 212, pp. 525-530, 2015.
W. A. Keitel, Jackson, L. A., Edupuganti, S., Winokur, P. L., Mulligan, M. J., Thornburg, N. J., Patel, S. M., Rouphael, N. G., Lai, L., Bangaru, S., McNeal, M. M., Bellamy, A. R., Hill, H. R., and Group, T. V. T. E. U. - H. 3Nv, Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons >/=18 Years Old, J Infect Dis, vol. 212, pp. 552-561, 2015.
W. A. Keitel, Campbell, J. D., Treanor, J. J., Walter, E. B., Patel, S. M., He, F., Noah, D. L., and Hill, H., Safety and Immunogenicity of an Inactivated Influenza A/H5N1 Vaccine Given Without or With Aluminum Hydroxide to Healthy Adults: Results of a Phase I-II Randomized Clinical Trial, J Infec Dis, vol. 198, pp. 1309-1316, 2009.
L. P. Stadler, Bernstein, D., Callahan, S. T., Turley, C. B., Munoz, F. M., Ferreira, J., Acharya, M., Simone, G. A. Gorgone, Patel, S. M., Edwards, K. M., and Rosenthal, S. L., Seroprevalence and Risk Factors for Cytomegalovirus Infections in Adolescent Females, J Ped Infec Dis, vol. 2, pp. 7-14, 2013.